Need help? Contact us at (800) 824-8540

News & Blog

Antibodies Partners with Dr. Gregory Kapatos, Producer of Highly-Cited Mouse Monoclonal anti-Tyrosine Hydroxylase (LNC1), to Expand Product Portfolio

Antibodies Partners with Dr. Gregory Kapatos, Producer of Highly-Cited Mouse Monoclonal anti-Tyrosine Hydroxylase (LNC1), to Expand Product Portfolio

View story
Antibodies Incorporated is proud to announce our collaboration with Gregory Kapatos, Ph.D. to develop antibodies against critical targets modulating gene expression. Dr. Kapatos personally developed the best-selling anti-tyrosine hydroxylase antibody LNC1 and brings a wealth of experience to help guide our antibody development efforts.

PhosphoSolutions Joins the Antibodies and Aves Team

View story
Antibodies Incorporated and Aves Labs are proud to announce their new partnership with PhosphoSolutions, an Aurora, Colorado-based team of scientis...
Antibodies Incorporated awarded contract for 5-year project to develop up to 100 mouse monoclonal antibodies to support discovery of novel cancer biomarkers and therapeutics.

Antibodies Incorporated awarded contract for 5-year project to develop up to 100 mouse monoclonal antibodies to support discovery of novel cancer biomarkers and therapeutics.

View story
    Reproducibility Crisis A major source of frustration among scientists is the lack of high-quality antibodies available for use in their resear...
Antibodies is Attending the 71st AACC Annual Scientific Meeting & Clinical Lab Expo

Antibodies is Attending the 71st AACC Annual Scientific Meeting & Clinical Lab Expo

View story

The 71st AACC meeting will take place August 4-8, 2019 at the Anaheim Convention Center in California. The American Association for Clinical Chemistry (AACC) organizes the conference, and all members of the global laboratory medicine community are welcome to attend. The conference is a chance to connect with global leaders in the sciences, learn about new technology, and important changes in the field. Attendees will also examine advances in medicine in the context of our changing healthcare environment.  

2019 Keystone Symposia on Neuroninflammation and Neurodegenerative Disease Contest Results

View story
Antibodies Incorporated was proud to sponsor the 2019 Keystone Symposia on Neuroninflammation and Neurodegenerative Disease. The Contest Question I...
20 µL Trial Size NeuroMabs Now Available

20 µL Trial Size NeuroMabs Now Available

View story
Make your next discovery faster with trial size antibodies. We often receive requests from the scientific community for smaller-volume versions of ...

An Article Worth a (Re)read

View story
As we begin the 14th year of our collaboration with NeuroMab, Antibodies Incorporated wishes to acknowledge the diligent efforts that, under the le...

Join Us at Neuroscience 2018!

View story
Antibodies and Aves will be at Neuroscience 2018 at the San Diego Convention Center from November 3 - 7, 2018. We'll be at booths 3327 (Aves) and 3...

Antibodies Incorporated Signs Long-Term Extension to UC Davis / NIH Neuromab Contract

View story
Antibodies Incorporated is pleased to announce the signing of a multi-year extension to its existing arrangement as commercial partner of the UC Da...